4D Molecular Therapeutics, Inc. (FDMT) Presents at Morgan Stanley 23rd Annual Global
Question-and-Answer SessionSo with that, we have Dave and Chris here representing the company. Maybe we can just start out with -- for those less familiar with 4D, could you provide a brief intro to the company and the gene therapy platform?David KirnCo-Founder, CEO & Director Sure, Judah. Thanks for having us. It's great to be here. So at 4D, we're a next-generation genetic medicines and gene therapy company. Our fundamental platform underlying our products is the use of directed evolution and Nobel Prize ...